Aura Biosciences Inc. (AURA)
7.72
0.16 (2.12%)
At close: Jan 15, 2025, 3:59 PM
7.73
0.13%
After-hours Jan 15, 2025, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -76.41M | -58.76M | -35.25M | -22.21M | -24.20M |
| Depreciation & Amortization | 1.29M | 1.18M | 831.00K | 831.00K | 509.00K |
| Stock-Based Compensation | 8.77M | 6.41M | 2.31M | 736.00K | 507.00K |
| Other Working Capital | 5.48M | -3.44M | -1.37M | -1.96M | 1.42M |
| Other Non-Cash Items | -1.95M | -325.00K | 4.00K | -3.00K | 43.00K |
| Deferred Income Tax | n/a | n/a | 14.00K | n/a | 11.00K |
| Change in Working Capital | 4.44M | -3.10M | -315.00K | -3.68M | 2.46M |
| Operating Cash Flow | -63.85M | -54.60M | -32.41M | -24.32M | -20.67M |
| Capital Expenditures | -709.00K | -1.09M | -2.13M | -771.00K | -2.22M |
| Acquisitions | n/a | 66.78K | n/a | n/a | n/a |
| Purchase of Investments | -233.65M | -119.78M | n/a | n/a | n/a |
| Sales Maturities Of Investments | 120.40M | 53.01M | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | -66.78K | n/a | n/a | n/a |
| Investing Cash Flow | -113.96M | -67.87M | -2.13M | -771.00K | -2.22M |
| Debt Repayment | n/a | n/a | n/a | n/a | -37.00K |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | -13.00K |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 94.12M | 87.08M | 87.56M | 19.94M | 39.76M |
| Financial Cash Flow | 97.29M | 95.63M | 166.26M | 10.04M | 39.73M |
| Net Cash Flow | -80.52M | -26.84M | 131.72M | -15.06M | 16.84M |
| Free Cash Flow | -64.56M | -55.70M | -34.53M | -25.09M | -22.89M |